← Open Payments lookup

MICHAEL CARROLL: Open Payments

NPI 1346338324 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,459 in 135 payments from 21 companies in 2025. Trend: 2023 $2,614 · 2024 $2,886 · 2025 $2,459

Food & beverage: $2,459
CompanyPaymentsAmount
ABBVIE INC.34$564
AstraZeneca Pharmaceuticals LP14$334
GlaxoSmithKline, LLC.14$266
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$189
PFIZER INC.8$152
Otsuka America Pharmaceutical, Inc.10$149
Lilly USA, LLC7$142
Amgen Inc.12$129
Vanda Pharmaceuticals Inc.4$92
Astellas Pharma US Inc4$77

Products named: VRAYLAR, REXULTI, TRELEGY ELLIPTA, UBRELVY, CAPLYTA, NEXIUM, FANAPT, JARDIANCE.

Industry payments across MI — which companies pay providers there.